Capítulo 3 - Asociación Española Síndrome de Prader Willi

BOPER, R.T., MASON, E.E., PRINTER, K.J., y ZELLWAGER, H. (1981): “Surgical Treatment of morbid
obesity in PWS”, en The Prader-Willi Syndrome, University Park Press, 121-135.
BRAY, G.A. (1992): “Genetic, hypothalamic and endocrine features of clinical experimental
obesity”, Progress in Brain Research, 93, 333-340.
BRAY, G.A.,DAHMS, W.T., SWERDLOFF, R.S., FISER, R.H., ATKINSON, R.L., y CARREL, R.E.
(1983): The Prader-Willi syndrome: A study of 40 patients and a review of the literature,
Medicine, 60, 59-80.
BUTLER, M.G., y MEANEY, F.J. (1991): “Standards for selected anthropometric measurements
in Prader-Willi syndrome”, Pediatrics, 88, 853-860.
GOTLIN, R., DUBOIS, R., MACE, J., y MYER, W. (1972): “Carbohydrate metabolism in the
Prader-Willi syndrome”, Clinical Research, 20, 274 (abstract).
ILLIG, R., TSCHURNI, A., y VISCHER, D. (1975): “Glucose intolerance and diabetes mellitus
in patients with the Prader-Labhart-Willi syndrome”, Modern Problems in Pediatrics,
12, 203-210.
LINDGREN, A.C., HAGENÄIS, L., MÜLLER, J., BLICHFELDT, S., ROSENBORG, M., BRISMAR, T. y
RITZÉN, E.M. (1998): “Growth hormone treatment of children with PWS affects linear
growth and body composition favourably”, Acta Paediatr, 87, 28-31.
O´HALLORAN, D.J., TSATSOULIS, A., WHITEHOUSE, R.W., HOLMES, S.J., ADAMS, J.E., y SHALET,
S.M. (1993): “Increased bone density after recombinant human growth hormone (GH)
therapy in adults with isolated GH deficiency”, Journal of Clinical Endocrinology and
Metabolism, 76, 1344-1348.
PRADER, A. (1981): “The Prader-Willi syndrome: An overview”, Acta Pædiatrica Japonica,
23, 307-311.
RITZÉN, E.M., BOLME, P., y HALL, K. (1992): “Endocrine physiology and therapy in Prader-
Willi syndrome”, en CASSIDY, S.B. (ed.), Prader Willi Syndrome, NATO ASI Series,
vol. H 61, Heidelberg: Springer-Verlag, 154-169.
ROBINSON, W.P., BOTTANI, A., XIE, Y.G., BALAKRISHMAN, J., BINKERT, F., Machler, M., PRADER,
A., y SCHINZEL, A. (1991): “Molecular, cytogenetic, and clinical investigations of Prader-
Willi syndrome patients”, American Journal of Human Genetics, 49, 1219-1234.
ROSENBAUM, M., GERTNER, J.M., y LEIBEL, R.L. (1989): “Effects of systemic growth hormone
(GH) administration on regional adipose tissue distribution and metabolism in GH-deficient
children”, Journal of Clinical Endocrinology and Metabolism, 69, 1274-1281.
RUDD, B.T., CHANCE, G.W., y THEODORIDIS, G.C. (1969): “Adrenal response to ACTH in
patients with Prader-Willi syndrome, simple obesity, and constitutional dwarfism”,
Archives of Diseases in Childhood, 44, 244-247.
SARREN, C., RUVALCABA, R.H.A., y KELLEY, V.C. (1975): “Some aspects of carbohydrate metabolism
in Prader-Willi syndrome”, Journal of Mental Deficiency Research, 19, 113-119.
SEYLER, L.E., ARUNLANANTHAM, K, y O´CONNOR, C.F. (1979): “Hypergonadotropic-hypogonadism
in the Prader-Labhart-Willi syndrome”, Journal of Pediatrics, 94, 435-437.
62